Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
BMJ Open Ophthalmology|March 14, 2024
Saffron therapy for the ongoing treatment of age-related macular degenerationGeoffrey K Broadhead, John Grigg, Peter J McCluskey, et al.
International Ophthalmology|July 16, 2020
Does functional assessment predict everyday visual functioning? Visual function testing and quality of life in mild/moderate age-related macular degenerationGeoffrey K Broadhead, Thomas Hong, John R Grigg, et al.
Clinical & Experimental Ophthalmology|February 4, 2012
Long-term outcomes of phacoemulsification cataract surgery performed by trainees and consultants in an Australian cohortCalvin Sze-un Fong, Paul Mitchell, Tania de Loryn, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 12, 2025
Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical ConsequencesKimberly Leanne Spooner, Samantha Fraser-Bell, Hemal Mehta, et al.
Ophthalmology. Retina|October 16, 2025
How to Judge Failure: Defining Treatment Resistance to Anti-VEGF Therapy in Exudative Maculopathies-A Systematic Scoping ReviewGeoffrey K Broadhead, Long Phan, Tiarnán D L Keenan, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 11, 2014
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomesMeidong Zhu, Jamie K Chew, Geoffrey K Broadhead, et al.
Plos Pathogens|January 11, 2020
Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHVNenavath Gopal Naik, Thomas Hong Nguyen, Lauren Roberts, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 31, 2016
Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degenerationMeidong Zhu, Wijeyanthy Wijeyakumar, Adil R Syed, et al.
Open Forum Infectious Diseases|March 30, 2022
Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort StudyHaYoung Ryu, Sana Mohayya, Thomas Hong, et al.
Ophthalmic Research|December 5, 2015
Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy OutcomesAndrew A Chang, Geoffrey K Broadhead, Thomas Hong, et al.
Pageof 8